apcca2019_032_session 6: biomarkers in cholangiocarcinoma
Published 5 years ago • 100 plays • Length 24:58Download video MP4
Download video MP3
Similar videos
-
26:48
apcca2019_012_session 2: hepatopancreaticoduodenectomy (hpd) for cholangiocarcinoma
-
3:52
understanding your biomarker test report
-
0:15
🧠 arteries of the brain: the lifelines of cerebral function 🧠
-
20:18
apcca2019_034_session 6: clinical trials incorporating translational targets
-
6:31
understanding cholangiocarcinoma
-
4:11
cholangiocarcinoma patient matt reidy's biomarker story
-
5:06
cholangiocarcinoma - mayo clinic
-
0:16
afib catheter ablation biomarker – two chamber view
-
29:21
apcca2019_035_session 6: liver-directed therapy for cholangiocarcinoma
-
24:45
apcca2019_013_session 2: liver transplantation for cholangiocarcinoma
-
3:32
for cholangiocarcinoma patients, biomarkers matter
-
45:20
webinar: role of ceacam6 as a biomarker in cholangiocarcinoma
-
17:37
apcca2019_009_session 1: what is the best approach for biopsy and stenting hilar cholangiocarcinoma?
-
2:05
q6 - reducing ci-aki incidence in tavr procedures
-
20:09
apcca2019_033_session 6: drugs and targets in development
-
9:57
2018 cholangiocarcinoma foundation annual conference #10 - day 3 - biomarker data from abc-06
-
4:08
for healthcare providers treating cholangiocarcinoma, biomarkers matter
-
28:50
apcca2019_016_session 3a: precision medicine on the horizon for cholangiocarcinoma
-
1:22
dr. kaplan on the combination of ibrutinib and venetoclax in mcl
-
1:22
if i am concerned about dissection, what should i pay attention to when using cvi?
-
22:47
apcca2019_010_session 2: surgical approach to intrahepatic cholangiocarcinoma